Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STON2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | ARHGDIG | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | MRGPRX4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
mRNA | KEL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | MASP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | PBRM1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | SLC17A4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | PEA15 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
mRNA | MYSM1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | IGFBP4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |